Skip to contentL
Lisata Therapeutics, Inc.
L
LSTALisata Therapeutics, Inc. Released Mar 8, 2013, after the close
10-K filed Mar 11, 2013, 70 days after period end · 0000320017-13-000009
Q4 2011 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.75M$2.75Mderivedno prior Q4 2010 on file No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
−38.0% vs Q3 2011
Net Income-$15.51M-$15.51MderivedN/M vs Q4 2010N/M vs Q3 2011 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$241,161N/M Operating Incomederived-$7,942,760N/M Operating Cash Flowderived-$9,624,887N/M Free Cash Flowderived-$9,958,625N/M Margins · derivedGross margin8.8%
Operating margin-288.7%
Net margin-563.6%
Filing lag
ended Dec 31, 2012 · filed Mar 11, 2013 · 70 d after period end